Current Affairs

GK MCQs Section

A joint report titled “Clinical Trial Opportunities in India” Report was released recently by the PwC India and...

📅 May 6, 2023

The US Food and Drug Administration (FDA) has approved lecanemab, a monoclonal antibody developed by Eisai and Biogen,...

📅 January 9, 2023

The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat...

📅 January 31, 2022

The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to...

📅 October 10, 2020

On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first...

📅 July 3, 2020

Health and Family Welfare Ministry have issued the Drugs and Clinical Trials Rules, 2019 with a motive to...

📅 March 26, 2019

As per the data of the Drug Controller-General of India, India recorded 2061 drug trial-related deaths during the...

📅 August 25, 2012

A regulatory mechanism in Biodiversity sector to be in place following the recommendations Objective: To safeguard public health...

📅 February 16, 2012